0G4 Stock Overview
Provides crop productivity solutions. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Bioceres Crop Solutions Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$5.95 |
52 Week High | US$12.30 |
52 Week Low | US$5.45 |
Beta | 0.47 |
11 Month Change | -4.80% |
3 Month Change | -31.61% |
1 Year Change | -43.87% |
33 Year Change | -53.52% |
5 Year Change | n/a |
Change since IPO | -46.88% |
Recent News & Updates
Recent updates
Shareholder Returns
0G4 | DE Chemicals | DE Market | |
---|---|---|---|
7D | 2.6% | -1.0% | -0.02% |
1Y | -43.9% | -2.0% | 8.2% |
Return vs Industry: 0G4 underperformed the German Chemicals industry which returned -2% over the past year.
Return vs Market: 0G4 underperformed the German Market which returned 8.2% over the past year.
Price Volatility
0G4 volatility | |
---|---|
0G4 Average Weekly Movement | 8.3% |
Chemicals Industry Average Movement | 4.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 0G4's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 0G4's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | n/a | Federico Trucco | investors.biocerescrops.com/home/default.aspx |
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Bioceres Crop Solutions Corp. Fundamentals Summary
0G4 fundamental statistics | |
---|---|
Market cap | €369.97m |
Earnings (TTM) | €2.35m |
Revenue (TTM) | €423.71m |
157.7x
P/E Ratio0.9x
P/S RatioIs 0G4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0G4 income statement (TTM) | |
---|---|
Revenue | US$441.23m |
Cost of Revenue | US$265.14m |
Gross Profit | US$176.09m |
Other Expenses | US$173.65m |
Earnings | US$2.44m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.039 |
Gross Margin | 39.91% |
Net Profit Margin | 0.55% |
Debt/Equity Ratio | 72.3% |
How did 0G4 perform over the long term?
See historical performance and comparison